Patents by Inventor Karin Steinike

Karin Steinike has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 7-azaindoles and the use thereof as therapeutic agents
    Patent number: 7947705
    Abstract: The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: May 24, 2011
    Assignee: Biotie Therapies GmbH
    Inventors: Norbert Höfgen, Hildegard Kuss, Matthias Olbrich, Ute Egerland, Chris Rundfeldt, Karin Steinike, Rudolf Schindler
  • 7-Azaindoles and the use thereof as therapeutic agents
    Publication number: 20070161671
    Abstract: The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Application
    Filed: March 6, 2007
    Publication date: July 12, 2007
    Inventors: Nobert Hofgen, Hildegard Kuss, Matthias Olbrich, Ute Egerland, Chris Rundfeldt, Karin Steinike, Rudolf Schindler
  • 7-azaindoles and the use thereof as therapeutic agents
    Patent number: 7211583
    Abstract: The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: May 1, 2007
    Assignee: Elbion AG
    Inventors: Nobert Höfgen, Hildegard Kuss, Matthias Olbrich, Ute Egerland, Chris Rundfeldt, Karin Steinike, Rudolf Schindler
  • 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
    Patent number: 7067536
    Abstract: The invention relates to substituted 4-, 6- or 7-hydroxyindoles with N-oxide groups, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: June 27, 2006
    Assignee: Elbion AG
    Inventors: Nobert Hofgen, Hildegard Kuss, Karin Steinike, Ute Egerland, Chris Rundfeldt
  • 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
    Publication number: 20060128758
    Abstract: The invention relates to substituted 4-, 6- or 7-hydroxyindoles with N-oxide groups, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Application
    Filed: January 30, 2006
    Publication date: June 15, 2006
    Inventors: Nobert Hofgen, Hildegard Kuss, Karin Steinike, Ute Egerland, Chris Rundfeldt
  • 5-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
    Publication number: 20040266760
    Abstract: The invention relates to substituted 5-hydroxyindoles with N-oxide groups, processes for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Application
    Filed: April 14, 2004
    Publication date: December 30, 2004
    Inventors: Nobert Hofgen, Hildegard Kuss, Karin Steinike, Ute Egerland, Chris Rundfeldt, Thomas Pfeifer
  • 4-,6- or 7-hydroxyindoles with N-oxide groups and the use thereof as therapeutic agents
    Publication number: 20040242643
    Abstract: The invention relates to substituted 4-,6- or 7-hydroxyindoles with N-oxide groups, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Application
    Filed: April 16, 2004
    Publication date: December 2, 2004
    Inventors: Nobert Hofgen, Hildegard Kuss, Karin Steinike, Ute Egerland, Chris Rundfeldt
  • 7-azaindoles and the use thereof as therapeutic agents
    Publication number: 20040224971
    Abstract: The invention relates to substituted 7-azaindoles, process for their preparation, pharmaceutical preparations which comprise these compounds, and the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 4, as active ingredients for the treatment of disorders which can be influenced by inhibition of phosphodiesterase 4 activity in particular in immunocompetent cells (e.g. macrophages and lymphocytes) by the compounds of the invention.
    Type: Application
    Filed: April 16, 2004
    Publication date: November 11, 2004
    Inventors: Nobert Hofgen, Hildegard Kuss, Matthias Olbrich, Ute Egerland, Chris Rundfeldt, Karin Steinike, Rudolf Schindler